Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
CTKB Cytek Biosciences
13.390+0.150+1.13%
Close
02/03 16:00 ET
13.3900.0000.00%
Post Mkt Price 02/03 16:04 ET
High
13.510
Open
13.010
Turnover
13.48M
Low
12.775
Pre Close
13.240
Volume
1.02M
Post-Market
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
Cytek Biosciences, Inc. (NASDAQ:CTKB) Short Interest Update
Cytek Biosciences, Inc. (NASDAQ:CTKB – Get Rating) saw a large increase in short interest during the month of January. As of January 15th, there was short interest totalling 3,970,000 shares, an inc
Cytek Biosciences, Inc. (NASDAQ:CTKB) Holdings Raised by Allspring Global Investments Holdings LLC
Allspring Global Investments Holdings LLC grew its stake in shares of Cytek Biosciences, Inc. (NASDAQ:CTKB – Get Rating) by 54.4% in the 3rd quarter, according to the company in its most recent Form
Cytek Biosciences, Inc. (NASDAQ:CTKB) CFO Patrik Jeanmonod Sells 3,500 Shares
Cytek Biosciences, Inc. (NASDAQ:CTKB – Get Rating) CFO Patrik Jeanmonod sold 3,500 shares of the company's stock in a transaction on Tuesday, January 24th. The stock was sold at an average price of $
Ming Yan Sells 20,000 Shares of Cytek Biosciences, Inc. (NASDAQ:CTKB) Stock
Cytek Biosciences, Inc. (NASDAQ:CTKB – Get Rating) CTO Ming Yan sold 20,000 shares of the firm's stock in a transaction on Thursday, January 19th. The shares were sold at an average price of $11.03,
Cytek Biosciences (NASDAQ:CTKB) Shares Down 7.5%
Cytek Biosciences, Inc. (NASDAQ:CTKB – Get Rating) shares dropped 7.5% during mid-day trading on Thursday . The company traded as low as $10.91 and last traded at $10.92. Approximately 9,581 shares w
Cytek Biosciences (NASDAQ:CTKB) Shares Down 3% Following Insider Selling
Cytek Biosciences, Inc. (NASDAQ:CTKB – Get Rating)'s stock price was down 3% during trading on Wednesday after an insider sold shares in the company. The company traded as low as $10.32 and last trad
Oak Street Health, PriceSmart And Some Other Big Stocks Moving Higher In Tuesday's Pre-Market Session
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today's pre-market trading session.Sotera Health Company (NASDAQ:SHC) shares climbed 42.7% to $12.33 in pre-m
Global Flow Cytometry Market Report to 2027 - Players Include Bio-Techne, Cell Signaling Technology, Coherent and Cytek Biosciences - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Flow Cytometry: Products, Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering. This report aims to provide a comprehensive study o
Cytek Biosciences, Inc. (NASDAQ:CTKB) Sees Significant Growth in Short Interest
Cytek Biosciences, Inc. (NASDAQ:CTKB – Get Rating) was the recipient of a large increase in short interest during the month of December. As of December 15th, there was short interest totalling 3,470,
Cytek Biosciences (NASDAQ:CTKB) Shareholders Have Endured a 37% Loss From Investing in the Stock a Year Ago
Company Overview
More
Cytek Biosciences, Inc. is a life sciences technology company engaged in the provision of cell analysis tools by leveraging novel technical approaches. Its products include Cytek Aurora CS, Cytek Aurora, Cytek Northern Lights, and Cytek NL-CLC. The company was founded by Wenbin Jiang and Ming Yan in December 2014 and is headquartered in Fremont, CA.
CEO： Dr. Wenbin Jiang, PhD
Market： NASDAQ
Listing Date： 07/23/2021
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet